United States: Court Dismisses Class Action Against Biopharmaceutical Company For Failing To Disclose Progress Of Competitor; Second Circuit Affirms Dismissal Of Putative Class Action Against Allergan; Eleventh Circuit Affirms That

United States: Court Dismisses Class Action Against Biopharmaceutical Company For Failing To Disclose Progress Of Competitor; Second Circuit Affirms Dismissal Of Putative Class Action Against Allergan; Eleventh Circuit Affirms That "Toxic" Lender Qualifie

Mondaq

Published

Goodwin's Securities and Shareholder Litigation and White Collar Defense lawyers have extensive experience before US federal and state courts, as well as with regulatory and enforcement agencies.

Full Article